Related Experiment Video
Updated: Mar 22, 2026
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
1.0K
Protease-activated receptors in hemostasis.
1Department of Pharmacology, Case Western Reserve University, Cleveland, OH.
Blood
|April 30, 2016
Summary
Protease-activated receptors (PARs) initiate cell signaling through N-terminal cleavage. Their activity is modulated by membrane interactions and genetic factors, influencing cellular responses and therapeutic targeting.
Area of Science:
- Cellular biology
- Molecular signaling
- G-protein coupled receptors
Background:
- Protease-activated receptors (PARs) mediate crucial physiological responses.
- PARs (PAR1-4) are G-protein-coupled receptors activated by N-terminal cleavage.
- Signaling initiation is controlled by proteolysis efficiency, influenced by allosteric sites, cofactors, and dimerization.
Purpose of the Study:
- To review how PAR signaling is affected by alternative cleavage sites and membrane interactions.
- To understand the structural basis of PAR activation and allosteric control.
- To explore the therapeutic potential of targeting PARs.
Main Methods:
- Review of existing literature on PAR signaling pathways.
- Analysis of factors influencing PAR activation and downstream signaling.
- Examination of genetic and epigenetic controls on PARs.
Main Results:
- PAR signaling is regulated by N-terminal cleavage efficiency, allosteric modulation, and receptor interactions.
- PAR1 signaling is influenced by proteases and heterodimerization with PAR2 or PAR3.
- Genetic variations (polymorphisms) in PAR4 affect reactivity and platelet response.
Conclusions:
- Membrane interactions and structural rearrangements are key to PAR activation and signaling output.
- Understanding PAR allosteric control is crucial for therapeutic development.
- Genetic and epigenetic factors significantly influence PAR function and cellular behavior.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.1K
01:05Introduction to Hemostasis
16.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
16.1K
01:22Formation of the Platelet Plug
10.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.8K
01:22Amplifying Signals via Enzymatic Cascade
19.1K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K